Cargando…

Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors

Patients with advanced solid tumors may receive intensive treatments near the end of life. This study aimed to create a machine learning (ML) model using limited features to predict 6-month mortality at treatment decision points (TDPs). METHODS: We identified a cohort of adults with advanced solid t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalkidis, George, McPherson, Jordan, Beck, Anna, Newman, Michael, Yui, Shuntaro, Staes, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067363/
https://www.ncbi.nlm.nih.gov/pubmed/35467965
http://dx.doi.org/10.1200/CCI.21.00163
_version_ 1784699992106074112
author Chalkidis, George
McPherson, Jordan
Beck, Anna
Newman, Michael
Yui, Shuntaro
Staes, Catherine
author_facet Chalkidis, George
McPherson, Jordan
Beck, Anna
Newman, Michael
Yui, Shuntaro
Staes, Catherine
author_sort Chalkidis, George
collection PubMed
description Patients with advanced solid tumors may receive intensive treatments near the end of life. This study aimed to create a machine learning (ML) model using limited features to predict 6-month mortality at treatment decision points (TDPs). METHODS: We identified a cohort of adults with advanced solid tumors receiving care at a major cancer center from 2014 to 2020. We identified TDPs for new lines of therapy (LoTs) and confirmed mortality at 6 months after a TDP. Using extreme gradient boosting, ML models were developed, which used or derived features from a limited set of electronic health record data considering the literature, clinical relevance, variability, availability, and predictive importance using Shapley additive explanations scores. We predicted and observed 6-month mortality after a TDP and assessed a risk stratification strategy with different risk thresholds to support communication of chance of survival. RESULTS: Four thousand one hundred ninety-two patients were included. Patients had 7,056 TDPs, for which the 6-month mortality increased from 17.9% to 46.7% after starting first to sixth LoT, respectively. On the basis of internal validation, models using both 111 (Full) or 45 (Limited-45) features accurately predicted 6-month mortality (area under the curve ≥ 0.80). Using a 0.3 risk threshold in the Limited-45 model, the observed 6-month survival was 34% (95% CI, 28 to 40) versus 81% (95% CI, 81 to 82) among those classified with low or higher chance of survival, respectively. The positive predictive value of the Limited-45 model was 0.66 (95% CI, 0.60 to 0.72). CONCLUSION: We developed and validated a ML model using a limited set of 45 features readily derived from electronic health record data to predict 6-month prognosis in patients with advanced solid tumors. The model output may support shared decision making as patients consider the next LoT.
format Online
Article
Text
id pubmed-9067363
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-90673632022-05-04 Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors Chalkidis, George McPherson, Jordan Beck, Anna Newman, Michael Yui, Shuntaro Staes, Catherine JCO Clin Cancer Inform ORIGINAL REPORTS Patients with advanced solid tumors may receive intensive treatments near the end of life. This study aimed to create a machine learning (ML) model using limited features to predict 6-month mortality at treatment decision points (TDPs). METHODS: We identified a cohort of adults with advanced solid tumors receiving care at a major cancer center from 2014 to 2020. We identified TDPs for new lines of therapy (LoTs) and confirmed mortality at 6 months after a TDP. Using extreme gradient boosting, ML models were developed, which used or derived features from a limited set of electronic health record data considering the literature, clinical relevance, variability, availability, and predictive importance using Shapley additive explanations scores. We predicted and observed 6-month mortality after a TDP and assessed a risk stratification strategy with different risk thresholds to support communication of chance of survival. RESULTS: Four thousand one hundred ninety-two patients were included. Patients had 7,056 TDPs, for which the 6-month mortality increased from 17.9% to 46.7% after starting first to sixth LoT, respectively. On the basis of internal validation, models using both 111 (Full) or 45 (Limited-45) features accurately predicted 6-month mortality (area under the curve ≥ 0.80). Using a 0.3 risk threshold in the Limited-45 model, the observed 6-month survival was 34% (95% CI, 28 to 40) versus 81% (95% CI, 81 to 82) among those classified with low or higher chance of survival, respectively. The positive predictive value of the Limited-45 model was 0.66 (95% CI, 0.60 to 0.72). CONCLUSION: We developed and validated a ML model using a limited set of 45 features readily derived from electronic health record data to predict 6-month prognosis in patients with advanced solid tumors. The model output may support shared decision making as patients consider the next LoT. Wolters Kluwer Health 2022-04-25 /pmc/articles/PMC9067363/ /pubmed/35467965 http://dx.doi.org/10.1200/CCI.21.00163 Text en © 2022 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle ORIGINAL REPORTS
Chalkidis, George
McPherson, Jordan
Beck, Anna
Newman, Michael
Yui, Shuntaro
Staes, Catherine
Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors
title Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors
title_full Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors
title_fullStr Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors
title_full_unstemmed Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors
title_short Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors
title_sort development of a machine learning model using limited features to predict 6-month mortality at treatment decision points for patients with advanced solid tumors
topic ORIGINAL REPORTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067363/
https://www.ncbi.nlm.nih.gov/pubmed/35467965
http://dx.doi.org/10.1200/CCI.21.00163
work_keys_str_mv AT chalkidisgeorge developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors
AT mcphersonjordan developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors
AT beckanna developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors
AT newmanmichael developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors
AT yuishuntaro developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors
AT staescatherine developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors